Press release
Global Late Stage Chronic Kidney Disease Drugs Market: Size, Growth Factors, and CAGR Analysis
Late Stage Chronic Kidney Disease Drugs Market Size
What Is The Projected Market Size Of The Global Late Stage Chronic Kidney Disease Drugs Market And Its Growth Rate?
The global late-stage chronic kidney disease drugs market has demonstrated significant growth in recent years due to numerous driving factors:
• The market will grow from $7.08 billion in 2024 to $7.92 billion in 2025, with a compound annual growth rate (CAGR) of 11.9%.
• This growth is due largely to improvements in diagnostic capabilities, an aging population, increasing incidence of diabetes and hypertension, heightened awareness of kidney diseases, and expansion of pharmaceutical research and development.
• The market size is projected to reach $12.2 billion in 2029, growing at a CAGR of 11.4%.
• The growth during this period can be attributed to factors such as increased healthcare expenditure, the adoption of precision medicine, a growing focus on regenerative medicine and patient-centered care, and worldwide initiatives to increase awareness of kidney disease.
What Is Driving The Growth In The Late Stage Chronic Kidney Disease Drugs Market?
The high prevalence of chronic kidney diseases is expected to propel the growth of the late-stage chronic kidney disease drug market forward. Chronic kidney diseases refer to a diverse range of conditions affecting the structure and function of the kidneys. Late-stage chronic kidney disease drugs are used to control blood pressure in patients, decrease protein loss to halt the progression of kidney damage, manage symptoms, and prevent consequences. The Centers for Disease Control and Prevention (CDC), a US-based public health agency, reported in May 2024 that an estimated 14% of U.S. adults, or around 35.5 million people, are believed to have chronic kidney diseases. Therefore, the increased prevalence of chronic kidney disease is driving the growth of the late-stage chronic kidney disease drug market.
Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12196&type=smp
Who Are the Key Players Driving Late Stage Chronic Kidney Disease Drugs Market Growth?
Significant players in the late stage chronic kidney disease drugs market include:
• Pfizer Inc.
• Johnson & Johnson
• AbbVie Inc.
• Bayer AG
• Novartis AG
• Sanofi SA
• Bristol-Myers Squibb Company
• AstraZeneca plc
• Eli Lilly and Company
• C.H. Boehringer Sohn AG & Co. KG
• Amgen Inc.
• Novo Nordisk A/S
• Teva Pharmaceutical Industries Ltd.
• Otsuka Pharmaceutical Co. Ltd.
• Takeda Pharmaceutical Company Limited
• Kyowa Kirin Co Ltd.
• OPKO Health Inc.
• Evotec SE
• Ionis Pharmaceuticals Inc.
• Akebia Therapeutics Inc.
• Ardelyx Inc.
• Concert Pharmaceuticals Inc.
• Pharmaxis Limited
• Deltanoid Pharmaceuticals Inc.
• Liminal BioSciences Inc.
• Chinook Therapeutics Inc.
• Allena Pharmaceuticals Inc
• Shield Therapeutics Plc
What Are The Key Trends In The Late Stage Chronic Kidney Disease Drugs Market?
The following trends are shaping the late-stage chronic kidney disease drugs market:
• Expansion of regenerative medicine therapies
• Rise in telemedicine services for CKD management
• Development of combination therapies
• Emphasis on early intervention strategies
• Growing interest in biomarker-based diagnostics
What Are The Segments Of The Global Late Stage Chronic Kidney Disease Drugs Market?
The late-stage chronic kidney disease drugs market is segmented by:
1) Product Type: Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders
2) Indication Type: Late Stage Chronic Kidney Disease Induced Hyperparathyroidism, Late Stage Chronic Kidney Disease Induced Hyperphosphatemia, Late Stage Chronic Kidney Disease Induced Hyperkalemia
3) Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
Which Region Leads The Late Stage Chronic Kidney Disease Drugs Market?
North America was the largest region in the late-stage chronic kidney disease drugs market in 2024. Other areas studied in the report include Asia-Pacific, Western Europe, Eastern Europe, South America, Middle East, Africa.
Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/late-stage-chronic-kidney-disease-drugs-global-market-report
What Is Covered In The Late Stage Chronic Kidney Disease Drugs Market Global Market Report?
- Market Size Analysis: Analyze the Late Stage Chronic Kidney Disease Drugs Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Late Stage Chronic Kidney Disease Drugs Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Late Stage Chronic Kidney Disease Drugs Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Late Stage Chronic Kidney Disease Drugs Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=12196&type=smp
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Late Stage Chronic Kidney Disease Drugs Market: Size, Growth Factors, and CAGR Analysis here
News-ID: 3834651 • Views: …
More Releases from The Business Research Company
Segment Analysis and Major Growth Areas in the Isoflavones Market
The isoflavones market is poised for remarkable growth over the coming years, driven by increasing consumer awareness and expanding applications across various industries. With rising interest in health supplements and natural ingredients, this market is attracting significant attention from manufacturers and investors alike. Let's delve into the market's size, key players, emerging trends, and segment breakdowns shaping its trajectory.
Projected Market Size and Growth Outlook for Isoflavones
The isoflavones market…
Key Strategic Developments and Emerging Changes Shaping the Infant Nutrition Mar …
The infant nutrition market is on track for substantial expansion in the coming years, driven by evolving consumer preferences and advancements in product offerings. As parents increasingly seek high-quality nutrition solutions tailored to their babies' needs, the sector is poised for remarkable growth through innovative products and diverse distribution channels. Let's explore the market's size projections, key players, emerging trends, and segment breakdowns shaping this dynamic industry.
Projected Growth Trajectory and…
Leading Companies Advancing Innovation and Growth in the Immune Health Supplemen …
The immune health supplements sector is gaining significant traction as consumers increasingly prioritize wellness and preventive care. With a growing interest in personalized nutrition and plant-based options, this market is set to expand rapidly. Let's explore the expected market size, key players, emerging trends, and segmentation that define the future of immune health supplements.
Projected Expansion of the Immune Health Supplements Market by 2030
The immune health supplements market is…
Honey Spread Market Overview: Major Segments, Strategic Developments, and Leadin …
The honey spread market is gaining significant momentum as consumers increasingly seek healthier and more flavorful alternatives to traditional spreads. Growing awareness around natural ingredients and sustainability, combined with e-commerce expansion and innovative product offerings, is set to shape the future of this sector. Below, we explore the market's size, key players, emerging trends, and segmentation to provide a comprehensive outlook through 2030.
Robust Expansion Expected in the Honey Spread Market…
More Releases for Late
How Factoring Services Help Businesses with Late Payments
US customers pay their invoices late in over 50% of cases, causing cash flow disruptions, missed opportunities, and financial strain. Factoring services can fix these issues for you in almost no time. This financial solution converts unpaid invoices into immediate working capital in 24 hours.
If late payments are a constant challenge for your business, learn how you can take advantage of factoring to tackle it.
1. Get a steady cash flow
More…
Late Night Revelry Awaits at The Winslow Lounge - NYC's Premier Late-Night Desti …
Image: https://www.getnews.info/wp-content/uploads/2024/06/1713864312.jpeg
New York, NY - The Winslow Lounge, located in the heart of the East Village, has quickly become the premier late-night destination [https://thewinslownyc.com/late-night-bar-nyc/] in New York City. With its vibrant atmosphere, exciting entertainment options, delicious food and drinks, and lively events, The Winslow offers an unforgettable nightlife experience.
"We wanted to create a place in NYC where people could truly let loose and have an amazing time," said Mark Tafoya,…
Desperate Puppy Seeks Rescue Before It’s Too Late!
FOR IMMEDIATE RELEASE
Tucson AZ, December 14th, 2021
The StarBarksCoffee.com rescue team was recently assaulted and threatened with being shot for assisting an abused, entangled puppy.
This Video of a neglected puppy desperately seeking rescue from a mentally unstable and violently aggressive owner was taken recently at an RV park in Texas during our annual "Journey Across America" in support of Animal Welfare.
We've contacted Texas authorities, but the Sheriff’s Department informed us the…
Transform your Traditional Businesses Before Its Too Late
Mob Inspire, an app development company has disrupted many industries by providing innovative software solutions to traditional businesses. We understand the rapidly changing tech environment and therefore equipt ourselves with those skills and tech tools which enable us to deal with challenging situations efficiently.
Mob Inspire takes the leverage of the latest tech trends like Blockchain, IoT and Cloud to deliver high-end products to its clients. The popularity…
Late-Night Treats for Late-Night Peeps
WHAT: La Motta’s, the neighborhood favorite in Boston’s SoWa District, is rolling out the late-night red carpet for its hospitality industry folks and friends, with Chef de Cuisine Justin Winter’s creative twists on after-hours snacks. Available every Sunday - Thursday from 10:00PM to last call, La Motta’s is the neighborhood joint for a late-night bash with flavorful bites and brews.
Launching Sunday, February 26th, 2017, guests can expect flavorful options…
Late payment – the hidden challenge facing Europe's businesses
A recent Europe-wide business survey has revealed no improvement in the pressure on European businesses from customers’ late payments, with 55 per cent of businesses across Europe reporting late payments resulting in loss of income, 63 per cent claiming additional pressures on liquidity, and 50 per cent citing late payments as having a direct impact on company growth.
In the Republic of Ireland, 47 per cent of businesses surveyed claimed…
